Enhancing the Clinical Effectiveness of Depression Screening Using Patient-targeted Feedback in General Practices
Depression
About this trial
This is an interventional screening trial for Depression focused on measuring Depression, Screening, Primary Care, General Practice, Feedback
Eligibility Criteria
Inclusion Criteria:
- Gender: male, female, diverse
- Maximum Age: no maximum age
- Attendance in primary care with medical consultation
- Age ≥ 18 years;
- Sufficient language skills;
- Informed consent
- Patient Health Questionnaire-9 > 9 points
Exclusion Criteria:
- Life threatening health status;
- Severe somatic or/and psychological disorder that needs urgent treatment;
- Known diagnosis of a depressive disorder
- Current depression treatment
- Acute suicidal tendency;
- Severe cognitive or/and visual difficulties;
- Not being able to fill out questionnaires
- No contact details
Sites / Locations
- University Medical Center Heidelberg
- University Medical Center Tuebingen
- Technical University of Munich - Medical Faculty
- University Medical Center Jena
- University Medical Center Hamburg
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
PATIENT-GP-FEEDBACK
GP-FEEDBACK
NO-FEEDBACK
Using a randomized-controlled study design one third of the patients and their attending general practitioner will receive feedback after depression screening. The feedback for the patient contains the screening result, information about depression in general, guideline based treatment recommendations for patients and contact-information for treatment. The feedback for the general practitioner contains the screening result and guideline-based recommendations, i.e. to inform patients of their depression screening result. Nevertheless, in order to reflect routine clinical practice, the physicians will decide themselves whether or not to address depression during their consultation with the patient.
Using a randomized-controlled study design in one third of the cases only the attending general practitioner will receive feedback after depression screening. The feedback for the general practitioner contains the screening result and guideline-based recommendations, i.e. to inform patients of their depression screening result. Nevertheless, in order to reflect routine clinical practice, the physicians will decide themselves whether or not to address depression during their consultation with the patient.
Using a randomized-controlled study design one third of the patients and their attending general practitioner will not receive any feedback.